LabVantage lanza CORTEX: LIMS potenciado por IA para laboratorios

LabVantage Solutions has introduced a new artificial intelligence–driven platform designed to transform how laboratories manage data, workflows, and automation. The company announced the launch of LabVantage CORTEX, a next-generation platform that combines artificial intelligence (AI), advanced analytics, and automation technologies…

Read MoreLabVantage lanza CORTEX: LIMS potenciado por IA para laboratorios

Genentech Reports Positive Phase II Results for Petrelintide in Overweight and Obesity

Genentech Reports Positive Phase II Results for Petrelintide, an Amylin Analog for Overweight and Obesity Genentech, a member of the Roche Group today announced positive topline results from the Phase II ZUPREME-1 trial evaluating the investigational drug petrelintide versus placebo…

Read MoreGenentech Reports Positive Phase II Results for Petrelintide in Overweight and Obesity

Vertex Presents Latest Evidence Demonstrating JOURNAVX®’s Efficacy in Managing Pain Following Cosmetic and Reconstructive Surgery

Vertex Pharmaceuticals Announces Phase 4 Data Demonstrating JOURNAVX® Enables Opioid-Free Recovery Following Aesthetic and Reconstructive Procedures Vertex Pharmaceuticals Incorporated today announced new data from a Phase 4 study evaluating JOURNAVX® (suzetrigine), a prescription non-opioid pain signal inhibitor, for the management…

Read MoreVertex Presents Latest Evidence Demonstrating JOURNAVX®’s Efficacy in Managing Pain Following Cosmetic and Reconstructive Surgery

Worley and Bloomfire Partner to Deliver Enterprise Intelligence in Energy & Chemicals

Bloomfire Partners with Worley Consulting to Transform Knowledge Management in Energy, Chemicals, and Resources Sectors Bloomfire has announced a strategic partnership with Worley Consulting, a leading provider of advisory solutions across the energy, chemicals, and resources sectors. The collaboration will…

Read MoreWorley and Bloomfire Partner to Deliver Enterprise Intelligence in Energy & Chemicals

Modular Genetics Joins New American Industrial Alliance to Reindustrialize U.S

Modular Genetics, Inc. Joins New American Industrial Alliance to Drive U.S. Reindustrialization Modular Genetics, Inc. (Modular), a leading Industrial Biotechnology company, is proud to announce its membership in the New American Industrial Alliance (NAIA), a move that positions the company…

Read MoreModular Genetics Joins New American Industrial Alliance to Reindustrialize U.S

BioMed Realty & CordenPharma Expand Peptide Lab at LEED Gold Facility in Boulder

BioMed Realty and CordenPharma Colorado Expand Peptide Development Capacity with New Facility in Boulder BioMed Realty, a leading private owner and operator of real estate dedicated to the life sciences, technology, and innovation sectors, has announced a major new partnership…

Read MoreBioMed Realty & CordenPharma Expand Peptide Lab at LEED Gold Facility in Boulder

NEJM Publishes First Evidence of Disease Modification in Dravet Syndrome

New Study in NEJM Highlights Potential Disease-Modifying Treatment for Dravet Syndrome Biotechnology company Stoke Therapeutics and global neuroscience firm Biogen have announced the publication of important new research on the investigational medicine zorevunersen in the prestigious medical journal The New…

Read MoreNEJM Publishes First Evidence of Disease Modification in Dravet Syndrome

Americhem Launches PFAS-Free Thermoplastic Platform for Aircraft Interiors

Americhem Expands Aircraft Interior Portfolio with PFAS-Free Thermoplastic Platform Americhem has announced the expansion of its aircraft interior materials portfolio with the introduction of ColorFast® SFT5500, a PFAS-free high-performance thermoplastic designed specifically for aerospace interior applications. The new material platform…

Read MoreAmerichem Launches PFAS-Free Thermoplastic Platform for Aircraft Interiors